| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/04/2023 | 112.23% | HC Wainwright & Co. | $18 → $17 | Maintains | Buy |
| 06/21/2023 | 124.72% | HC Wainwright & Co. | → $18 | Reiterates | Buy → Buy |
| 04/06/2023 | 99.75% | Cantor Fitzgerald | $12 → $16 | Maintains | Overweight |
| 04/04/2023 | 124.72% | HC Wainwright & Co. | → $18 | Reiterates | → Buy |
| 03/31/2023 | 124.72% | HC Wainwright & Co. | → $18 | Reiterates | → Buy |
| 01/26/2023 | 124.72% | HC Wainwright & Co. | → $18 | Reiterates | → Buy |
| 11/22/2022 | 49.81% | Cantor Fitzgerald | $9 → $12 | Upgrades | Neutral → Overweight |
| 10/20/2022 | 124.72% | HC Wainwright & Co. | $14 → $18 | Maintains | Buy |
| 09/26/2022 | 137.2% | Wedbush | $11 → $19 | Maintains | Outperform |
| 09/07/2022 | 37.33% | Capital One | → $11 | Initiates Coverage On | → Overweight |
| 08/08/2022 | 74.78% | Craig-Hallum | → $14 | Assumes | → Buy |
| 06/03/2021 | 74.78% | HC Wainwright & Co. | $15 → $14 | Maintains | Buy |
| 04/21/2021 | 112.23% | Craig-Hallum | → $17 | Initiates Coverage On | → Buy |
| 04/19/2021 | 49.81% | Maxim Group | → $12 | Initiates Coverage On | → Buy |
| 06/05/2020 | 124.72% | Cantor Fitzgerald | → $18 | Initiates Coverage On | → Overweight |
| 05/15/2020 | 87.27% | HC Wainwright & Co. | $17 → $15 | Reiterates | → Buy |
| 09/17/2018 | 99.75% | Wedbush | $17 → $16 | Maintains | Outperform |
What is the target price for Fennec Pharmaceuticals (FENC)?
The latest price target for Fennec Pharmaceuticals (NASDAQ: FENC) was reported by HC Wainwright & Co. on August 4, 2023. The analyst firm set a price target for $17.00 expecting FENC to rise to within 12 months (a possible 112.23% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fennec Pharmaceuticals (FENC)?
The latest analyst rating for Fennec Pharmaceuticals (NASDAQ: FENC) was provided by HC Wainwright & Co., and Fennec Pharmaceuticals maintained their buy rating.
When is the next analyst rating going to be posted or updated for Fennec Pharmaceuticals (FENC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fennec Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fennec Pharmaceuticals was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
Is the Analyst Rating Fennec Pharmaceuticals (FENC) correct?
While ratings are subjective and will change, the latest Fennec Pharmaceuticals (FENC) rating was a maintained with a price target of $18.00 to $17.00. The current price Fennec Pharmaceuticals (FENC) is trading at is $8.01, which is out of the analyst's predicted range.